Evidence map›Paper›PMID 37047425›Full record

ArticleInternational journal of molecular sciences2023

Pyrogallol from

Punnida Arjsri, Sariya Mapoung, Warathit Semmarath, Kamonwan Srisawad, Wirote Tuntiwechapikul, Supachai Yodkeeree, Pornngarm Dejkriengkraikul

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 12 citations in OpenAlex.

  1. Molecular Effects ofInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Punnida ArjsriDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0001-6249-4497
Sariya MapoungDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-4180-1712
Warathit SemmarathDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0001-6340-9653
Kamonwan SrisawadDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.
Wirote TuntiwechapikulDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0003-1365-476X
Supachai YodkeereeDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0001-9023-2283
Pornngarm DejkriengkraikulDepartment of Biochemistry, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand.ORCID 0000-0001-8732-8911
Chiang Mai University · TH

Funding

Faculty of Medicine, Chiang Mai University 055-2564Post-Doctoral Fellowship Program, Chiang Mai University 9/2022Royal Golden Jubilee Scholarship PhD. Program (RGJ) PHD/0172/2558
6 · The paper itself

Abstract

Castration-resistant prostate cancer (CRPC) is an advanced form of prostate cancer associated with poor survival rates. The high proliferation and metastasis rates have made CRPC one of the most challenging types of cancer for medical practitioners and researchers. In this study, the anti-cancer properties and inhibition of CRPC progression by

Indexed as

Prostatic Neoplasms, Castration-ResistantSpirogyraApoptosisbeta CateninCell Line, TumorCell ProliferationGlycogen Synthase Kinase 3 betaHumansMaleNeglectaProto-Oncogene Proteins c-aktPyrogallolSignal Transductionbeta CateninGlycogen Synthase Kinase 3 betaProto-Oncogene Proteins c-aktPyrogallolanti-cancer propertiesapoptosis inductioncancer cells proliferationcastration-resistant prostate cancerpyrogallolSpirogyra neglectaβ-catenin signaling pathway

Identifiers

PMID37047425
PMCPMC10094533
OpenAlexW4361275984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.